Product Details
| Product Name:
MJN228 |
CAS No.:
459168-97-9 |
| Purity:
98.42% |
Supply Ability:
10g |
| Release date:
2025/11/09 |
Product Introduction
Bioactivity
| Name | MJN228 |
| Description | MJN228 is a lipid-binding protein nucleobindin-1 (NUCB1) inhibitor that blocks the AEA-DA probe labeling of endogenous NUCB1 in Neuro2a cells and can be used for the study of metabolic disorders. |
| In vitro | 25 μM MJN228 significantly reduced lipid probe labeling of NUCB1 in Neuro2a cells. [1]
MJN228 interfered with multiple intracellular lipid metabolic pathways. [1] |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 20 mg/mL (54.88 mM), Sonication is recommended.
|
| Keywords | MJN228 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:1597440-03-3
$88.00 / 1mg
-
CAS:908115-27-5
$33.00 / 1mg
-
CAS:6483-15-4
$45.00 / 5mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States